Skip to main content
SpringerLink
Log in

Duloxetine mitigates adverse drug events following chemo, back pain

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. following first-line treatment with paracetamol [acetaminophen]

References

  1. Wielage RC, et al. The Cost-Effectiveness of Duloxetine in Chronic Low Back Pain: A US Private Payer Perspective. Value in Health 16: 334-44, No. 2, Mar 2013. Available from: URL: http://dx.doi.org/10.1016/j.jval.2012.12.006

    Article  PubMed  Google Scholar 

  2. Smith EM, et al. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA: the Journal of the American Medical Association 309: 1359-67, No. 13, 3 Apr 2013. Available from: URL: http://dx.doi.org/10.1001/jama.2013.2813

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Duloxetine mitigates adverse drug events following chemo, back pain. Reactions Weekly 1448, 3 (2013). https://doi.org/10.1007/s40278-013-2505-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-013-2505-3

Search

Navigation